Human Fetal Hemoglobin (HBF-1) FITC Conjugate
Check against the official notice below — it lists the full affected range.
Life Technologies Corporation has recalled three lots of Human Fetal Hemoglobin (HBF-1) FITC Conjugate due to a defect that causes high background staining and unusual bright staining in control and patient samples. This staining problem could lead to erroneous test results, including false positives. The affected lots are Lot# 1626670D, Lot# 1873068B, and Lot# 1915224B (Model # MHFH01), which were distributed across 16 states including Michigan, California, Illinois, Texas, New York, and others.
The recall notice does not specify a remedy or instructions for what affected consumers should do in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
Three lots of Human Fetal Hemoglobin FITC Conjugate are displaying high background and unusual bright staining in the controls and patient samples which could potentially lead to erroneous results (i.e. false positives)
Reason for recall: Three lots of Human Fetal Hemoglobin FITC Conjugate are displaying high background and unusual bright staining in the controls and patient samples which could potentially lead to erroneous results (i.e. false positives) Distribution: MI, CA, IL, TX, SC, NY, MN, DE, NJ, WA , OR, IN, MA, DE, FL, PA Lot/code info: Model # MHFH01 UDI (01)10190302005579(17)180430 (10)1626670D(240)MHFH01 Lot# 1626670D Model # MHFH01 UDI (01)10190302005579(17)190830 (10)1873068B(240)MHFH01 Lot# 1873068B Model # MHFH01 UDI (01)10190302005579(17)191030 (10)1915224B(240)MHFH01 Lot# 1915224B
Official record: FDA (Device enforcement) ↗
Republished from the official source above; details can change — the source record controls.